A federal biotechnology commission visited Seattle to hear from local industry leaders about the gap between biotech research and domestic manufacturing, and what it will take to keep the U.S. competitive with China. Read More
A biomanufacturing facility in Everett that Pfizer decided to shut down before it opened is getting a new lease on life, with a new owner and a 21-year lease to an unnamed global biopharmaceutical company. Read More
